PureTech Health plc PTCHF
1.64 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
1.56 Day range 1.56
1.45 52-week range 1.92
- YTD
- -4.09%
- 1 year
- -2.38%
News
businesswire.com PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Presents Data from Phase 1 Trial of GlyphAgo at European College of Neuropsychopharmacology Congress.
proactiveinvestors.com PureTech Health gets Panmure Liberum ‘buy' on value and cash returns PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) is undervalued ahead of potential shareholder cash returns, according to Panmure Liberum, which initiated coverage with a ‘buy' rating and…
businesswire.com PureTech Health: Results of Annual General Meeting BOSTON--(BUSINESS WIRE)--PureTech Health: Results of Annual General Meeting.
proactiveinvestors.com PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Therapeutics has priced an upsized US initial...
proactiveinvestors.co.uk PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Therapeutics has priced an upsized US initial public offering at the top of its target…
seekingalpha.com PureTech Health plc (PRTC) Q4 2025 Earnings Call Transcript PureTech Health plc (PRTC) Q4 2025 Earnings Call Transcript
defenseworld.net Short Interest in PureTech Health plc (OTCMKTS:PTCHF) Expands By 69.4% PureTech Health plc (OTCMKTS:PTCHF - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling…
proactiveinvestors.com Cavendish sees Poolbeg’s POLB 001 gaining strategic importance as CRS research expands Cavendish has taken an upbeat view of Poolbeg Pharma PLC's (AIM:POLB, OTC:POLBF) prospects after the company’s anti-inflammatory candidate POLB 001 was...
proactiveinvestors.com Greengage plans AQSE float with bold Bitcoin-backed lending strategy Fintech Greengage has set out plans to list on the Access segment of the Aquis Growth Market... and it is doing so with an unusually ambitious twist....
proactiveinvestors.com Puretech gains after FDA meeting post-Phase II trial PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF) shares rose 4.9% to 128p on Wednesday after the company said it had completed a successful end-of-Phase 2...
proactiveinvestors.com Coinsilium notes Greengage’s plan to float on Aquis Coinsilium Group Limited (AQSE:COIN, OTCQB:CINGF) has welcomed news that Greengage, one of its portfolio companies, intends to list on the Aquis Stock...
benzinga.com Stocks That Hit 52-Week Highs On Tuesday